CWA Asset Management Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Sell
4,167
-231
-5% -$18.6K 0.01% 573
2026
Q1
$381K Sell
4,398
-706
-14% -$67.6K 0.01% 527
2025
Q4
$490K Sell
5,104
-1,651
-24% -$160K 0.02% 463
2025
Q3
$643K Sell
6,755
-981
-13% -$90.2K 0.02% 432
2025
Q2
$674K Sell
7,736
-205
-3% -$17.4K 0.03% 407
2025
Q1
$714K Buy
7,941
+2,189
+38% +$196K 0.03% 362
2024
Q4
$459K Buy
5,752
+1,113
+24% +$96.3K 0.02% 399
2024
Q3
$418K Buy
+4,639
New +$390K 0.02% 393
2024
Q1
$589K Buy
6,761
+2,195
+48% +$187K 0.04% 299
2023
Q4
$376K Buy
+4,566
New +$348K 0.03% 292
2023
Q3
Sell
-2,873
Closed -$253K 370
2023
Q2
$253K Sell
2,873
-964
-25% -$83K 0.02% 312
2023
Q1
$309K Sell
3,837
-214
-5% -$17.4K 0.02% 257
2022
Q4
$315K Sell
4,051
-6,064
-60% -$491K 0.03% 258
2022
Q3
$817K Buy
10,115
+266
+3% +$23.9K 0.08% 131
2022
Q2
$884K Sell
9,849
-488
-5% -$49.4K 0.08% 129
2022
Q1
$1.15M Buy
10,337
+357
+4% +$37.7K 0.09% 124
2021
Q4
$1.03M Buy
9,980
+138
+1% +$16K 0.08% 135
2021
Q3
$1.23M Buy
9,842
+718
+8% +$92.9K 0.1% 128
2021
Q2
$1.15M Buy
9,124
+291
+3% +$36.5K 0.09% 124
2021
Q1
$1.04M Buy
8,833
+120
+1% +$14.1K 0.1% 123
2020
Q4
$1.02M Buy
8,713
+85
+1% +$9.36K 0.11% 121
2020
Q3
$897K Buy
8,628
+1,099
+15% +$110K 0.12% 105
2020
Q2
$690K Buy
7,529
+4,227
+128% +$405K 0.12% 99
2020
Q1
$298K Buy
+3,302
New +$351K 0.06% 166

Other funds holding MDT

CWA Asset Management Group's MDT Position: Q2 2026 in Review

CWA Asset Management Group reduced its Medtronic (MDT) stake by 5.3% in Q2 2026, selling an estimated $18.6K and leaving 4,167 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #573.

CWA Asset Management Group first reported a position in MDT in Q1 2020 and has held it in 24 quarters since. The position peaked at $1.23M in Q3 2021. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • CWA Asset Management Group held 4,167 shares of Medtronic worth $326K as of Q2 2026.
  • CWA Asset Management Group sold 231 Medtronic shares in Q2 2026, an estimated $18.6K.
  • Medtronic made up 0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #573 holding.
  • CWA Asset Management Group first reported a position in Medtronic in Q1 2020 and has held it in 24 quarters since.
  • CWA Asset Management Group's Medtronic position peaked at $1.23M in Q3 2021.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.